Jim Davis Group Wins Carpal Rx Marketing Contract

PALM CITY, Fla. - Aug. 2, 2016 - PRLog -- Director of Sales for Carpal Pain Solutions, John Bowen announces that the Jim Davis Group will head the company's efforts to continue marketing the Carpal Rx for at least two years.

"The remarkable response we've had from customers, doctors and therapists have catapulted the Carpal Rx farther and faster than we had anticipated", said Bowen. "The Davis Group is very experienced in managing fast-growth products like the Carpal Rx."

The company has been successfully marketing the Carpal Rx for several years. But its growth has been outpacing - and straining - the company's marketing capabilities. The outside marketing responsibilities will allow the company to focus on other core functions.

Carpal tunnel syndrome is characterized by tingling, numbness, pain, soreness, and weakness in the hand and fingers. It occurs with jobs that involve heavy hand use, like hairdressers, carpenters, and musicians. Almost 5 million Americans suffer with this potentially debilitating condition. Until the Carpal Rx was introduced, somebody suffering with carpal tunnel syndrome didn't have many options, other than hand surgery. The Carpal Rx is so successful because it enables hand pain sufferers to cure their condition in a matter of weeks. Statistics show that most of those patients go back to their former occupation. As a result of its effectiveness, many chiropractors and therapist have incorporated the Carpal Rx into their daily practice. This is why the company is focusing on assisting the growing number of healthcare professionals around the world who are prescribing the Carpal Rx.

Bowen says, "Davis [Group] has taken the pressure off, so now we can concentrate on growing our professional business side. We're happy they're aboard!"

Learn more at http://www.CarpalRx.com